65841-830 : Voriconazole 50 mg Oral Tablet
NDC: | 65841-830 |
Labeler: | Cadila Healthcare Limited |
Product Type: | Human Prescription Drug |
Drug Name: | Voriconazole |
Dosage Form: | Oral Tablet |
Application #: | ANDA206747 |
Rev. Date: |
Appearance:
Markings: | 735 |
Shapes: |
Round |
Colors: |
White |
Size (mm): | 7 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 65841-830-01: 100 TABLET IN 1 BOTTLE (65841‑830‑01)
- 65841-830-05: 500 TABLET IN 1 BOTTLE (65841‑830‑05)
- 65841-830-06: 30 TABLET IN 1 BOTTLE (65841‑830‑06)
- 65841-830-10: 1000 TABLET IN 1 BOTTLE (65841‑830‑10)
- 65841-830-16: 90 TABLET IN 1 BOTTLE (65841‑830‑16)
- 65841-830-77: 10 BLISTER PACK IN 1 CARTON (65841‑830‑77) > 10 TABLET IN 1 BLISTER PACK (65841‑830‑30)
Active Ingredients:
- Voriconazole
Dosage Strength:
- 50 mg
Inactive Ingredients:
- Croscarmellose Sodium
- Hypromellose 2910 (6 Mpa.s)
- Lactose Monohydrate
- Magnesium Stearate
- Polyethylene Glycol 6000
- Povidone K29/32
- Starch, Pregelatinized Corn
- Talc
- Titanium Dioxide
Pharmaceutical Classes:
- Azole Antifungal [EPC]
- Azoles [CS]
- Cytochrome P450 2C19 Inhibitors [MoA]
- Cytochrome P450 2C9 Inhibitors [MoA]
- Cytochrome P450 3A4 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 65841-831 Voriconazole 200 mg Oral Tablet by Cadila Healthcare Limited
- 70771-1413 Voriconazole 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Cadila Healthcare Limited
- 0093-5289 Voriconazole 50 mg Oral Tablet by Teva Pharmaceuticals USA Inc
- 0093-5290 Voriconazole 200 mg Oral Tablet by Teva Pharmaceuticals USA Inc
- 0378-1626 Voriconazole 50 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-1640 Voriconazole 200 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-6270 Voriconazole 40 mg/ml Oral Powder, for Suspension by Mylan Pharmaceuticals Inc.
- 0781-3416 Voriconazole 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
- 0781-5667 Voriconazole 50 mg Oral Tablet by Sandoz Inc
- 0781-5668 Voriconazole 200 mg Oral Tablet by Sandoz Inc
- 0904-6471 Voriconazole 200 mg Oral Tablet, Film Coated by Major Pharmaceuticals
- 0904-6596 Voriconazole 50 mg Oral Tablet by Major Pharmaceuticals
- 0904-7024 Voriconazole 200 mg Oral Tablet by Major Pharmaceuticals
- 14335-080 Voriconazole 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hainan Poly Pharm. Co., Ltd.
- 14335-220 Voriconazole 40 mg/ml Oral Powder, for Suspension by Hainan Poly Pharm. Co., Ltd
- 16714-198 Voriconazole 50 mg Oral Tablet, Film Coated by Northstar Rx LLC
- 16714-199 Voriconazole 200 mg Oral Tablet, Film Coated by Northstar Rx LLC
- 16714-514 Voriconazole 50 mg Oral Tablet by Northstar Rx LLC
- 16714-515 Voriconazole 200 mg Oral Tablet by Northstar Rx LLC
- 27241-062 Voriconazole 50 mg Oral Tablet by Ajanta Pharma Limited
- More related products ...
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 65841-829Next: 65841-831 >
Related Discussions:
Voriconazole and sun sensitivity
Does anyone have experience with skin sun sensitivity and extended voriconazole use for propholactic purposes (in immune... 3 replies
Does anyone have experience with skin sun sensitivity and extended voriconazole use for propholactic purposes (in immune... 3 replies
Voriconazole use problems!
Just finished my first 4 months on Vori & prednisone. Other than what my docs tell me I have no other source to find...
Just finished my first 4 months on Vori & prednisone. Other than what my docs tell me I have no other source to find...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.